- 2021-08-24 09:18:38
- LAST MODIFIED: 2025-04-06 00:21:03
GLG on AMR: Hasina seeks technology transfer to ensure equitable access to medical facilities, antibiotics

Photo Collected:
UNB Dhaka: Dhaka, Aug-24,
Prime Minister Sheikh Hasina has sought
continued collaboration from global leaders to keep up the momentum for
ensuring equitable access to affordable and effective antibiotics and other
medical facilities through technology transfer and sharing of ownership.
“Let’s work at the same time for partnership for
investment in Antimicrobial Resistance (AMR) containment,” she said on Tuesday.
The Prime Minister made the plea in her
pre-recorded speech at the Second Meeting of Global Leaders Group (GLG) on
Antimicrobial Resistance (AMR).
She said the AMR challenge requires sustained
action across sectors. “I’m pleased to
see the finalisation of the action plan in this regard. I’m also happy to
support the GLG priority advocating for financing and implementation of
multisectoral National Action Plans, with a One Health approach,” she said.
Hasina said she was glad to approve the
comprehensive communication strategy for the GLG. “We’ll do our part to raise the profile of
the GLG work through different networks.”
She mentioned that financing across sectors is
essential to reduce the burden of AMR.
“I look forward to hearing your ideas on what the GLG can do to increase
sustainable financing to directly address AMR.”
The Prime Minister gave importance to the need
to make sure that adequate funding is available for the national action plan
implementation, research and development, and for ensuring equitable access to
new innovations.
“Needless to say, we need to prioritise
political action to achieve our goal,” she said, adding that AMR should be
embedded in implementation of SDGs.
Talking about her own country, Hasina said
Bangladesh has developed a six-year (2017-2022) National Strategic Plan and
National Action Plan on Antimicrobial Resistance Containment.
“The Bangladesh AMR Response Alliance has also
been formed.”
She mentioned that Laboratory-based AMR
surveillance for both human and animal health are being conducted regularly to
ensure WHO categorisation.
“We’ve also been providing AMR surveillance data
to WHO GLASS Platform for the last two years.”
End/Dct/Unb/Sma/